BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25589066)

  • 1. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
    McClellan S; Jiang X; Barrett R; Hazlett LD
    J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
    Huang X; Du W; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.
    Ekanayaka SA; McClellan SA; Barrett RP; Kharotia S; Hazlett LD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5799-5809. PubMed ID: 27792814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.
    Li C; McClellan SA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(10):6886-900. PubMed ID: 25298414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea.
    Jiang X; McClellan SA; Barrett RP; Zhang Y; Hazlett LD
    J Immunol; 2012 Jul; 189(1):269-78. PubMed ID: 22661083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.
    McClellan SA; Ekanayaka SA; Li C; Jiang X; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8091-100. PubMed ID: 26720461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
    Kernacki KA; Barrett RP; Hobden JA; Hazlett LD
    J Immunol; 2000 Jan; 164(2):1037-45. PubMed ID: 10623854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF signaling impacts severity of Pseudomonas aeruginosa keratitis.
    Jiang X; McClellan SA; Barrett R; Foldenauer M; Hazlett LD
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2180-90. PubMed ID: 24618323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.
    Wu M; Peng A; Sun M; Deng Q; Hazlett LD; Yuan J; Liu X; Gao Q; Feng L; He J; Zhang P; Huang X
    Infect Immun; 2011 Jul; 79(7):2709-16. PubMed ID: 21555403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling.
    Huang X; Hazlett LD; Du W; Barrett RP
    J Immunol; 2006 Jul; 177(1):548-56. PubMed ID: 16785552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.
    Hazlett LD; McClellan SA; Barrett RP; Huang X; Zhang Y; Wu M; van Rooijen N; Szliter E
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1524-32. PubMed ID: 19892870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Langerhans cells in Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Rudner XL; Barrett RP
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):189-97. PubMed ID: 11773031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in resistance to P. aeruginosa ocular infection.
    Hazlett LD; McClellan S; Goshgarian C; Huang X; Thakur A; Barrett R
    Ocul Immunol Inflamm; 2005; 13(4):279-88. PubMed ID: 16159718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.